Portal Biotech
United Kingdom, London
About Portal Biotech
Portal Biotech is a London-based biotechnology company developing the world's first full-length, single-molecule protein sequencing platform using nanopore biosensing and AI-driven analysis. The company's technology enables rapid, cost-effective, and high-resolution protein characterization, making advanced proteomics accessible to everyday labs. Portal Biotech emerged from research at the Maglia Lab at the University of Groningen and is led by experts in nanopore genomics.
Latest Funding
Series AAnnounced 2025-06-30
Buying Signals
Where the capital is going, and whether it's already started moving.
Spend Intent
3 signals · where the capital is going
Advancing commercial rollout of the AI-powered proteomics platform
vestbee.com
+2 more capital deployment signals · confidence ratings · source articles
Sign up freeIn the news
Selling to Portal Biotech? You're in the right place.
Knowing they raised is the start. The edge is what's attached to Portal Biotech.
Spend intent
Where this round will be spent.
Hiring signals
Which departments are growing.
Verified contacts
Who actually decides.
No credit card required.
Ask AI
What is the unique value proposition of Portal Biotech, and who are their main competitors?
Sign up free to ask AI about Portal Biotech
Our AI has read their website, news, and funding history. 25 credits included with every free account.
Sign up free: 25 credits includedAuto-matched to your ICP
Every company, scored against your profile. Automatically.
Industry
High
Size
Mid
Stage
High
Match score blends industry, company size, growth stage, tech stack, and geography. The moment you set your ICP, every company in our database gets scored.
Investors
8VC
Lead investor · Series A
Tech Stack
HSTS
WordPress
PHP
Key Highlights
AI InsightsThe funding will accelerate commercialization, expand R&D, engineering, and data science teams, and deepen collaborations with pharmaceutical and biotech partners.
AI reads their website, press releases, and funding context to surface what makes them unique - so you tailor your pitch before the first call.
Try it free →Generates a personalized cold email based on their funding round, capital deployment signals, and company context. Ready to send in under 10 seconds.
Try it free →Short, personalized connection request crafted around their recent funding and what your product can help them achieve with it.
Try it free →Maps their competitive landscape with AI - invaluable context before your first call and for positioning your pitch against their alternatives.
Try it free →Extracts capital deployment signals from their funding news - reach out knowing exactly where they're investing and why your product fits.
Try it free →Similar Companies
Discover companies similar to Portal Biotech
Selling to Portal Biotech? You're in the right place.
Knowing they raised is the start. Our difference is what comes attached to Portal Biotech.
Spend Intent
Where this round will be spent.
Hiring Signals
Which departments are growing.
Verified Contacts
Who actually decides.
No credit card required.
Free weekly newsletter on startup funding.
20 rounds, ranked by amount. Industry and stage breakdowns. A short market note. One email, free, no noise. 2,000+ subscribers.
No spam, ever. Unsubscribe with one click.